Hualitai Co., Ltd.

Announcement of the Implementation of the 2025 Annual Equity Distribution

Legal Opinion from Beijing Hairun Tianrui (Hefei) Law Firm on the 2025 Annual Shareholders' Meeting of Anhui Hualitai Chemical Co., Ltd.

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Announcement on holding the 2025 annual results briefing

Anhui Waltai Chemical Co., Ltd. announced the 2025 Annual Results Briefing scheduled for May 12, 2026, from 16:00 to 17:00, to provide investors with insights into the company's performance and strategy. The briefing will be conducted via the Shenzhen Stock Exchange's Interactive Easy platform. Investors are encouraged to submit questions in advance to enhance the discussion. Contact details for inquiries are provided in the announcement.

Announcement on the renewal of accounting firms

2025 Independent Directors Debriefing Report (Hu Haichuan)

2025 Independent Director's Performance Report (George Wu)

George Wu's 2025 Independent Director Work Report for Anhui Huatai Chemical Co., Ltd. outlines his adherence to legal and regulatory frameworks while fulfilling his duties. He attended all board and shareholder meetings, actively participated in decision-making, and chaired the audit committee. The report highlights the approval of routine related transactions and confirms no violations of laws or regulations. Wu emphasized safeguarding minority shareholders' interests and maintaining transparent communication throughout his tenure.

2025 Independent Directors' Debriefing Report (Lou Yaohui)

2025 internal control audit report

2025 Internal Control Evaluation Report

The 2025 Internal Control Evaluation Report for Anhui Hualitai Chemical Co., Ltd. confirms that as of December 31, 2025, there are no significant deficiencies in both financial and non-financial reporting internal controls. The Board of Directors asserts that the company has maintained effective internal controls in compliance with regulatory standards. The evaluation covered all main units and high-risk areas, ensuring comprehensive oversight of operational management.

Remuneration management system for directors and senior managers

Announcement on the 2026 remuneration (allowance) plan for directors and senior managers

Announcement on the confirmation of daily related party transactions in 2025 and the forecast of daily related party transactions in 2026

Announcement on Application for Comprehensive Bank Credit Limit for 2026

Anhui Hualitai Chemical Co., Ltd. announced its application for a comprehensive bank credit line of up to RMB 2 billion for 2026, approved by the board of directors on April 22, 2026. This credit line aims to support the company's funding needs for production and operations. The application will be submitted for approval at the annual general meeting of shareholders in 2025, and the credit can be used repeatedly within its validity period. The management is authorized to handle specific loan applications within this credit line.

Notice on convening the 2025 annual shareholders' meeting

Announcement of Resolutions from the 9th Meeting of the 6th Board of Directors

The 9th Meeting of the 6th Board of Directors of Anhui Huartai Chemical Co., Ltd. was held on April 22, 2026, with all 9 directors present. Key resolutions included the approval of the 2025 Annual Work Report, General Manager Work Report, and Annual Report, all receiving unanimous support. Additionally, the board approved a proposal for a comprehensive credit line application of up to RMB 200 million for 2026, pending shareholder approval. All proposals will be submitted for deliberation at the upcoming annual shareholders' meeting.

Announcement on the 2025 profit distribution plan

First quarter report of 2026

Special audit report on the deduction of operating income in 2025

The 2025 accounting firm performance evaluation report and the audit committee's performance of supervision duties

Special explanation of the occupation of non-operating funds and other related capital transactions in 2025

Summary table of non-operating capital occupation and other related capital transactions

Special report of the board of directors on the self-examination of the independence of independent directors

2025 annual audit report

2025 Annual Report

2025 Annual Report Summary

Anhui Huatai Chemical Co., Ltd. released its 2025 Annual Report Summary, highlighting a profit distribution plan that includes cash dividends of 1 yuan per 10 shares. The company reported total assets of approximately 3.41 billion yuan, a decrease of 4.56% from the previous year. The basic chemical business is stable, while the fine chemical sector is in rapid growth. The report emphasizes the company's commitment to safety, environmental management, and market responsiveness.

Announcement on the action plan of "double improvement of quality return"

First quarter 2026 results forecast

2025 Annual Results Express

Legal Opinion on Share Acquisition by Wholly-Owned Subsidiary of Anhui Huatai Chemical Co., Ltd.

Beijing Hairun Tianrui Law Firm issued a legal opinion regarding the increase of shareholding in Anhui Hualitai Chemical Co., Ltd. by its controlling shareholder's wholly-owned subsidiary, Chizhou Shuncheng Technology Co., Ltd. The subsidiary acquired 1,228,600 shares, totaling RMB 15.87 million, representing 0.3702% of the total share capital. The acquisition complies with relevant laws and regulations, and the controlling shareholder plans further investments to support the company's development.

Announcement on the completion of the implementation of the plan for the controlling shareholder's wholly-owned subsidiary to increase its holdings of the company's shares

Announcement on Share Acquisition by Controlling Shareholder's Wholly-Owned Subsidiary and Subsequent Purchase Plan

Anhui Yaocheng Investment Group Co., Ltd. increased its shareholding in Anhui Huartai Chemical Co., Ltd. by 771,400 shares, representing 0.2324% of the total shares, on March 17, 2026. The controlling shareholder plans a Subsequent Increase Plan to invest at least RMB 15 million within six months, without a set price range, to support the company's development. The plan may face risks due to market changes, but it aims to stabilize and enhance the company's value.

Announcement of abnormal fluctuations in stock trading